e.l.f. Beauty, Inc. SEC filings document the public-company record for its NYSE-listed common stock and multi-brand beauty operations. The company’s Form 8-K filings report operating and financial results, material events, material agreements, capital-structure disclosures and board-level governance changes.
Proxy materials provide disclosure on shareholder voting matters, director elections, executive compensation, equity awards and governance practices. The filings connect these formal disclosures to e.l.f. Beauty’s operating model across cosmetics, skin care and related beauty brands, while documenting the company’s reporting obligations, security registration and corporate oversight structure.
Transaction and Credit Amendment (Aug 5, 2025)
e.l.f. Beauty, Inc. entered into a Fifth Amendment to its Amended and Restated Credit Agreement that: (i) establishes a new $600 million Term Facility, (ii) makes technical amendments to add the Term Facility, (iii) increases the maximum permitted consolidated total net leverage ratio covenant, and (iv) increases interest margins and unused-commitment fees on the existing Revolving Credit Facility. Term Facility pricing is at borrower election of SOFR + 1.50%–2.25% (SOFR floored at 0.00%) or an alternate base rate + 0.50%–1.25% (alternate base floored at 1.00%). Unused commitment fees on the revolver rose to 0.15% and 0.20% from 0.10% and 0.15% at the two lower pricing tiers. Amortization is 1.25% quarterly for the first three years, then 1.875% quarterly for two years, with final maturity on March 3, 2030. Proceeds are available to e.l.f. Cosmetics and certain subsidiaries for merger consideration, payoff of rhode's credit facility, fees/expenses and working capital.
Acquisition of rhode (Completed Aug 5, 2025)
e.l.f. and e.l.f. Cosmetics completed the acquisition of HRBeauty, LLC (rhode) pursuant to the May 28, 2025 Merger Agreement. Aggregate Closing Consideration was $800 million subject to adjustments, comprised of $600 million cash (approximate) and ~$200 million in common stock issued at $77.1685 per share based on the specified VWAP calculation. Contingent consideration (Earn-Out) of up to $200 million is payable based on three-year revenue performance: up to $100 million for achievement of projections and up to an additional $100 million for overachievement. Buyer funded a portion of the Closing Consideration with borrowings under the Amended Credit Agreement. The Company relied on Section 4(a)(2)/Rule 506 exemptions for the stock issuance and agreed to file a shelf registration covering resale of the shares. The Form 8-K attaches a press release for Q2 2025 results as Exhibit 99.1 and notes required financial statements and pro forma information for rhode will be filed within 71 days.